{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T03:29:40Z","timestamp":1764905380048},"reference-count":79,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.tem.2010.08.004","type":"journal-article","created":{"date-parts":[[2010,9,18]],"date-time":"2010-09-18T08:51:43Z","timestamp":1284799903000},"page":"691-698","source":"Crossref","is-referenced-by-count":30,"title":["Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor"],"prefix":"10.1016","volume":"21","author":[{"given":"Eric M.","family":"Jacobson","sequence":"first","affiliation":[]},{"given":"Eric R.","family":"Hugo","sequence":"additional","affiliation":[]},{"given":"Traci R.","family":"Tuttle","sequence":"additional","affiliation":[]},{"given":"Ruben","family":"Papoian","sequence":"additional","affiliation":[]},{"given":"Nira","family":"Ben-Jonathan","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2010.08.004_bib0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1210\/er.19.4.365","article-title":"Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features","volume":"19","author":"Lopez-Otin","year":"1998","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.tem.2010.08.004_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2007-0017","article-title":"What can we learn from rodents about prolactin in humans?","volume":"29","author":"Ben-Jonathan","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.tem.2010.08.004_bib0015","doi-asserted-by":"crossref","first-page":"19085","DOI":"10.1074\/jbc.M801202200","article-title":"Crystal structure of a prolactin receptor antagonist bound to the extracellular domain of the prolactin receptor","volume":"283","author":"Svensson","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2010.08.004_bib0020","doi-asserted-by":"crossref","first-page":"33118","DOI":"10.1074\/jbc.M704364200","article-title":"Structural and thermodynamic bases for the design of pure prolactin receptor antagonists: X-ray structure of Del1-9-G129R-hPRL","volume":"282","author":"Jomain","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2010.08.004_bib0025","doi-asserted-by":"crossref","first-page":"20022","DOI":"10.1074\/jbc.M109.084988","article-title":"Obligate ordered binding of human lactogenic cytokines","volume":"285","author":"Voorhees","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2010.08.004_bib0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ghir.2006.07.002","article-title":"Large-scale preparation and in vitro characterization of biologically active human placental (20 and 22K) and pituitary (20K) growth hormones: placental growth hormones have no lactogenic activity in humans","volume":"16","author":"Solomon","year":"2006","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.tem.2010.08.004_bib0035","doi-asserted-by":"crossref","first-page":"8422","DOI":"10.1074\/jbc.M109.089128","article-title":"Crystal structure of an affinity-matured prolactin complexed to its dimerized receptor reveals the topology of hormone binding site 2","volume":"285","author":"Broutin","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2010.08.004_bib0040","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/79047","article-title":"Ternary complex between placental lactogen and the extracellular domain of the prolactin receptor","volume":"7","author":"Elkins","year":"2000","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.tem.2010.08.004_bib0045","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1200\/JCO.2006.07.6356","article-title":"A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer","volume":"25","author":"Tworoger","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tem.2010.08.004_bib0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10911-008-9063-y","article-title":"Prolactin and breast cancer etiology: an epidemiologic perspective","volume":"13","author":"Tworoger","year":"2008","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.tem.2010.08.004_bib0055","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1210\/jc.2002-021255","article-title":"Prolactin expression and secretion by human breast glandular and adipose tissue explants","volume":"88","author":"Zinger","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2010.08.004_bib0060","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1038\/sj.onc.1206619","article-title":"Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice","volume":"22","author":"Rose-Hellekant","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.tem.2010.08.004_bib0065","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1172\/JCI119820","article-title":"Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice","volume":"100","author":"Wennbo","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2010.08.004_bib0070","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/A:1023956223037","article-title":"Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth","volume":"79","author":"Liby","year":"2003","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.tem.2010.08.004_bib0075","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/carcin\/bgp120","article-title":"Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase","volume":"30","author":"Lapensee","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tem.2010.08.004_bib0080","doi-asserted-by":"crossref","first-page":"R91","DOI":"10.1677\/ERC-09-0253","article-title":"Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy","volume":"17","author":"Lapensee","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.tem.2010.08.004_bib0085","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1038\/sj.onc.1205637","article-title":"Regulation of bcl-2 gene expression in human breast cancer cells by prolactin and its antagonist, hPRL-G129R","volume":"21","author":"Beck","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.tem.2010.08.004_bib0090","first-page":"1131","article-title":"A clinical study of taxotere versus taxotere plus the antiprolactinemic agent bromocriptine in metastatic breast cancer pretreated with anthracyclines","volume":"22","author":"Lissoni","year":"2002","journal-title":"Anticancer Res."},{"key":"10.1016\/j.tem.2010.08.004_bib0095","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2165\/00003495-200767090-00006","article-title":"HER2-positive breast cancer: current and future treatment strategies","volume":"67","author":"Engel","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.tem.2010.08.004_bib0100","doi-asserted-by":"crossref","first-page":"33937","DOI":"10.1074\/jbc.M000743200","article-title":"Constitutive tyrosine phosphorylation of ErbB-2 via Jak2 by autocrine secretion of prolactin in human breast cancer","volume":"275","author":"Yamauchi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2010.08.004_bib0105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10549-007-9789-z","article-title":"Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells","volume":"111","author":"Scotti","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.tem.2010.08.004_bib0110","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1074\/jbc.M109.066480","article-title":"Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells","volume":"285","author":"Carver","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2010.08.004_bib0115","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.1038\/sj.onc.1209740","article-title":"Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells","volume":"25","author":"Huang","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.tem.2010.08.004_bib0120","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10549-009-0400-7","article-title":"Prolactin and estradiol utilize distinct mechanisms to increase serine-118 phosphorylation and decrease levels of estrogen receptor alpha in T47D breast cancer cells","volume":"120","author":"Chen","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.tem.2010.08.004_bib0125","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ijc.1191","article-title":"Plasma prolactin and prostate cancer risk: a prospective study","volume":"92","author":"Stattin","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tem.2010.08.004_bib0130","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/en.2003-0415","article-title":"Gene expression analysis of prostate hyperplasia in mice overexpressing the prolactin gene specifically in the prostate","volume":"144","author":"Dillner","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2010.08.004_bib0135","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1210\/en.2006-1761","article-title":"Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a\/b signaling pathway","volume":"148","author":"Dagvadorj","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2010.08.004_bib0140","first-page":"6098","article-title":"A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice","volume":"61","author":"Xu","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.tem.2010.08.004_bib0145","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/molehr\/8.7.606","article-title":"Prolactin receptor expression in human testis and accessory tissues: localization and function","volume":"8","author":"Hair","year":"2002","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.tem.2010.08.004_bib0150","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/modpathol.2009.103","article-title":"Gene expression profiles of ductal versus acinar adenocarcinoma of the prostate","volume":"22","author":"Sanati","year":"2009","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.tem.2010.08.004_bib0155","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1158\/1078-0432.CCR-05-0562","article-title":"Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence","volume":"11","author":"Li","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tem.2010.08.004_bib0160","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1158\/0008-5472.CAN-07-2972","article-title":"Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells","volume":"68","author":"Tan","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.tem.2010.08.004_bib0165","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1677\/ERC-09-0328","article-title":"Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo","volume":"17","author":"Gu","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.tem.2010.08.004_bib0170","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.2353\/ajpath.2010.090653","article-title":"Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth","volume":"176","author":"Gu","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tem.2010.08.004_bib0175","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10911-008-9070-z","article-title":"The contribution of growth hormone to mammary neoplasia","volume":"13","author":"Perry","year":"2008","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.tem.2010.08.004_bib0180","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/pros.20203","article-title":"Basal growth hormone concentrations in blood and the risk for prostate cancer: a case-control study","volume":"64","author":"Fuhrman","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.tem.2010.08.004_bib0185","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1054\/ghir.2002.0271","article-title":"Co-expression of GH and GHR isoforms in prostate cancer cell lines","volume":"12","author":"Chopin","year":"2002","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.tem.2010.08.004_bib0190","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0002-9440(10)64071-0","article-title":"Growth hormone receptor is expressed in human breast cancer","volume":"158","author":"Gebre-Medhin","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tem.2010.08.004_bib0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mce.2004.03.004","article-title":"Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells","volume":"220","author":"Weiss-Messer","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2010.08.004_bib0200","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1210\/endo.142.2.7936","article-title":"The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor","volume":"142","author":"Kaulsay","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2010.08.004_bib0205","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/humupd\/dml048","article-title":"Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts","volume":"13","author":"Ferretti","year":"2007","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.tem.2010.08.004_bib0210","first-page":"4666","article-title":"Ectopic human chorionic gonadotropin beta secretion by epithelial tumors and human chorionic gonadotropin beta-induced apoptosis in Kaposi's sarcoma: is there a connection?","volume":"9","author":"Butler","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tem.2010.08.004_bib0215","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0140-6736(76)90731-5","article-title":"Prognostic significance of inappropriate production of pregnancy proteins by breast cancers","volume":"2","author":"Horne","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.tem.2010.08.004_bib0220","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/1097-0142(197704)39:4<1693::AID-CNCR2820390445>3.0.CO;2-Z","article-title":"Ectopic production of human placental lactogen by human breast tumors","volume":"39","author":"Sheth","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.tem.2010.08.004_bib0225","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/ajcp\/84.6.687","article-title":"Tumor marker expression in breast carcinomas and relationship to prognosis. An immunohistochemical study","volume":"84","author":"Lee","year":"1985","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.tem.2010.08.004_bib0230","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1074\/jbc.M609407200","article-title":"Lysyl oxidase interacts with hormone placental lactogen and synergistically promotes breast epithelial cell proliferation and migration","volume":"282","author":"Polgar","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2010.08.004_bib0235","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/0277-5379(88)90097-1","article-title":"Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: results of a double blind multicentre clinical trial","volume":"24","author":"Bonneterre","year":"1988","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/j.tem.2010.08.004_bib0240","first-page":"639","article-title":"Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects","volume":"17","author":"Ben-Jonathan","year":"1996","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.tem.2010.08.004_bib0245","first-page":"3583","article-title":"A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis","volume":"5","author":"Chen","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tem.2010.08.004_bib0250","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ncpendmet0270","article-title":"Drug Insight: prolactin-receptor antagonists, a novel approach to treatment of unresolved systemic and local hyperprolactinemia?","volume":"2","author":"Goffin","year":"2006","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2010.08.004_bib0255","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1517\/13543784.15.10.1257","article-title":"Therapeutic potential of S179D prolactin \u2013 from prostate cancer to angioproliferative disorders: the first selective prolactin receptor modulator","volume":"15","author":"Walker","year":"2006","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.tem.2010.08.004_bib0260","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bmc.2008.01.015","article-title":"Synthesis and screening of a cyclic peptide library: discovery of small-molecule ligands against human prolactin receptor","volume":"17","author":"Liu","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.tem.2010.08.004_bib0265","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/1087057106292473","article-title":"High-throughput screening: update on practices and success","volume":"11","author":"Fox","year":"2006","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.tem.2010.08.004_bib0270","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrd1086","article-title":"Hit and lead generation: beyond high-throughput screening","volume":"2","author":"Bleicher","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tem.2010.08.004_bib0275","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.tem.2010.08.004_bib0280","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00253-010-2578-3","article-title":"Synthetic biology approaches in drug discovery and pharmaceutical biotechnology","volume":"87","author":"Neumann","year":"2010","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.tem.2010.08.004_bib0285","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.str.2009.02.010","article-title":"Binding of small-molecule ligands to proteins: \u2018what you see\u2019 is not always \u2018what you get\u2019","volume":"17","author":"Mobley","year":"2009","journal-title":"Structure"},{"key":"10.1016\/j.tem.2010.08.004_bib0290","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1472-6750-8-11","article-title":"Quantification of PRL\/Stat5 signaling with a novel pGL4-CISH reporter","volume":"8","author":"Fang","year":"2008","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.tem.2010.08.004_bib0295","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ab.2010.04.007","article-title":"Development of cell-based assays for cytokine receptor signaling, using an AlphaScreen SureFire assay format","volume":"403","author":"Osmond","year":"2010","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.tem.2010.08.004_bib0300","doi-asserted-by":"crossref","first-page":"14533","DOI":"10.1073\/pnas.0800685105","article-title":"Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors","volume":"105","author":"Bogorad","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2010.08.004_bib0305","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1210\/jc.2009-1494","article-title":"Characterization of two constitutively active prolactin receptor variants in a cohort of 95 women with multiple breast fibroadenomas","volume":"95","author":"Courtillot","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2010.08.004_bib0310","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1185\/030079904125003232","article-title":"Could prolactin receptor gene polymorphism play a role in pathogenesis of breast carcinoma?","volume":"20","author":"Canbay","year":"2004","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.tem.2010.08.004_bib0315","first-page":"354","article-title":"Detection of prolactin messenger RNA in mammary and other normal and neoplastic tissues by polymerase chain reaction","volume":"68","author":"Fields","year":"1993","journal-title":"Lab. Invest."},{"key":"10.1016\/j.tem.2010.08.004_bib0320","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1023\/A:1005879103367","article-title":"Expression of the prolactin gene in normal and neoplastic human breast tissues and human mammary cell lines: promoter usage and alternative mRNA splicing","volume":"44","author":"Shaw-Bruha","year":"1997","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.tem.2010.08.004_bib0325","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1210\/endo.138.12.5605","article-title":"Expression of prolactin and its receptor in human breast carcinoma","volume":"138","author":"Reynolds","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2010.08.004_bib0330","first-page":"3094","article-title":"Expression of the gene encoding growth hormone in the human mammary gland","volume":"80","author":"Mol","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2010.08.004_bib0335","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/jcem.83.2.4564","article-title":"Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues","volume":"83","author":"Touraine","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2010.08.004_bib0340","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/(SICI)1097-0215(19980417)79:2<202::AID-IJC17>3.0.CO;2-B","article-title":"Cellular expression of growth hormone and prolactin receptors in human breast disorders","volume":"79","author":"Mertani","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tem.2010.08.004_bib0345","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10434-000-0305-5","article-title":"Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis","volume":"7","author":"Bhatavdekar","year":"2000","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.tem.2010.08.004_bib0350","first-page":"3692","article-title":"Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer","volume":"82","author":"Ormandy","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2010.08.004_bib0355","first-page":"2591","article-title":"Prolactin synthesis and secretion by human breast cancer cells","volume":"55","author":"Ginsburg","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.tem.2010.08.004_bib0360","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/bcr2129","article-title":"Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity","volume":"10","author":"Howell","year":"2008","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.tem.2010.08.004_bib0365","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0303-7207(02)00259-9","article-title":"Morphogenic and tumorigenic potentials of the mammary growth hormone\/growth hormone receptor system","volume":"197","author":"van","year":"2002","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2010.08.004_bib0370","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1677\/joe.0.171R001","article-title":"Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR","volume":"171","author":"Peirce","year":"2001","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.tem.2010.08.004_bib0375","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0002-9440(10)65333-3","article-title":"Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions","volume":"154","author":"Leav","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tem.2010.08.004_bib0380","first-page":"477","article-title":"Presence of the two growth hormone receptor messenger RNA isoforms in human breast cancer","volume":"6","author":"Decouvelaere","year":"1995","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.tem.2010.08.004_bib0385","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1749-6632.2002.tb04682.x","article-title":"Transcription of the human prolactin gene in mammary cells","volume":"973","author":"Baudhuin","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tem.2010.08.004_bib0390","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1172\/JCI119204","article-title":"Prolactin and prolactin receptors are expressed and functioning in human prostate","volume":"99","author":"Nevalainen","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2010.08.004_bib0395","doi-asserted-by":"crossref","first-page":"D298","DOI":"10.1093\/nar\/gkl952","article-title":"MMDB: annotating protein sequences with Entrez's 3D-structure database","volume":"35","author":"Wang","year":"2007","journal-title":"Nucleic Acids Res."}],"container-title":["Trends in Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276010001347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276010001347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T05:01:21Z","timestamp":1636520481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276010001347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":79,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S1043276010001347"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2010.08.004","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}